Cargando…
Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
OBJECTIVE: A multicenter, controlled trial showed that early blockade of the renin-angiotensin system in patients with type 1 diabetes and normoalbuminuria did not retard the progression of nephropathy, suggesting that other mechanism(s) are involved in the pathogenesis of early diabetic nephropathy...
Autores principales: | Li, Jinhua, Qu, Xinli, Yao, Jun, Caruana, Georgina, Ricardo, Sharon D., Yamamoto, Yasuhiko, Yamamoto, Hiroshi, Bertram, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279546/ https://www.ncbi.nlm.nih.gov/pubmed/20682692 http://dx.doi.org/10.2337/db09-1631 |
Ejemplares similares
-
Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy
por: Sun, Yu Bo Yang, et al.
Publicado: (2013) -
NOX2 Deficiency Protects Against Streptozotocin-Induced β-Cell Destruction and Development of Diabetes in Mice
por: Xiang, Fu-Li, et al.
Publicado: (2010) -
Intrarenal Dopamine Inhibits Progression of Diabetic Nephropathy
por: Zhang, Ming-Zhi, et al.
Publicado: (2012) -
Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy
por: Zhou, Yuxia, et al.
Publicado: (2023) -
Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
por: Eller, Kathrin, et al.
Publicado: (2011)